drive long-term profit growth
updat forecast estim aug
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research aug
estim aug
price data aug
rate updat aug
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
dupont de nemour world-renown chemic compani
histori span year ever-evolv portfolio
current iter dupont specialti chemic compani
creat dowdupont merger subsequ
separ compani four distinct busi line
gener roughli one fourth profit sell product differ
end market sale auto industri
end-market make dupont fairli diversifi
forecast consolid revenu grow slightli global
dupont produc noteworthi high-profit product
year safeti construct segment invent
product lycra kevlar wide applic
textil safeti equip teflon use nonstick
cookwar tyvek broadli use construct materi also
demonstr dupont success product develop
innov compani solid record innov
think abl replac earn older product
fall favor leapfrog new technolog
dupont well posit captur profit growth secular
trend come year transport advanc
polym segment dupont benefit automak
replac small metal piec lighter plastic trend
continu automak move toward lightweight
vehicl electron imag segment dupont
benefit continu growth semiconductor rise
interconnect devic requir electron
smartphon comput automobil
consum applianc dupont also expos electrif
vehicl compani gener revenu per
vehicl electr vehicl versu intern combust engin
dupont also second largest industri enzym produc
market share global novozym industri enzym
use produc laundri deterg ethanol fuel food
beverag anim feed
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
analyst note model pro forma model dupont histor financi
stand-alone entiti actual financi may differ
dupont diversifi global specialti chemic compani creat
dowdupont merger subsequ separ portfolio
includ chemic downstream product serv automot
electron commun construct healthcar safeti
protect industri dupont benefit abil produc patent
specialti chemic command price power noteworthi product
includ kevlar tyvek nomex tend wide rang
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fair valu estim per share base
discount cash flow model impli enterpris
value/adjust ebitda around time base
estim weight averag cost capit dupont
stage ii growth rate
reflect dupont price power develop
new patent product compani exposur
forecast low- mid-single-digit compound annual
organ sale growth next five year led gain
firm attract advanc materi electron
transport busi expect outpac
global growth dupont continu develop new
product forecast oper margin expand slightli
stay rang five-year explicit
roughli million relat toxic chemic lawsuit
environment cleanup expens upper end
dupont state liabil rang roughli half total
alreadi accru balanc
line
manag project addit liabil might
uncertainti rate dupont medium fair valu
estim depend compani abil continu
develop innov product dispar
busi line uncertain construct
three scenario -- base case describ valuat
section bull case bear case -- highlight rang
potenti outcom
bull case assum strong stabl global
market also assum faster growth semiconductor
connect technolog scenario dupont
success introduc innov high-margin product
electron materi segment dupont
safeti protect segment carri
mantl kevlar tyvek other transport
advanc polym segment benefit increas
market share per vehicl automot lightweight
per share
bear case assum protract slowdown
global econom recoveri weigh demand also
assum lack new product electron
materi busi slower growth semiconductor
connect technolog addit assum
slowdown automot lightweight electrif
weigh profit transport advanc
polym busi scenario dupont may forc
cut price stem share loss weigh margin
scenario assum dupont must pay addit
billion help fund chemours-rel toxic
chemic lawsuit environment cleaup expens
total billion bear case fair valu estim
award dupont narrow econom moat rate
intang asset base compani patent portfolio
specialti product compani success develop
innov materi creat group patent
product enjoy premium posit market
exampl dupont advanc materi busi
kevlar proprietari product becom materi
choic militari law enforc safeti
protect similarli nomex materi choic
firefight due heat resist properti tyvek
market-lead housewrap materi patent
product other dupont develop multipl version
end market product kevlar nomex
use consum industri applic
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
alreadi use patent product
think dupont proven abil
margin elev patent expir competitor develop
portfolio demand elev margin enjoy higher
barrier entri stickier custom relationship
confid dupont outearn cost capit
least next year
moat trend dupont stabl see offset
trend compani record develop innov
higher-margin product materi dupont
advanc materi electron busi
allow compani continu develop new
product would strengthen firm
competit advantag howev patent expir
greatli reduc profit product older
specialti chemic often fall favor
replac newer better product result dupont must
develop new product order maintain healthi profit
margin compani competit advantag
patent specialti chemic remain intact
materi strengthen weaken
compani health nutrit busi benefit
switch cost result acquisit fmc
health nutrit busi novemb
nutrit bioscienc segment hous health
nutrit busi key product includ microcrystallin
cellulos mcc use bind dri tablet
roughli half prescript written year
market function nonact ingredi
control releas polym although
signific drug patent expir come year
expect busi continu hold high market
share due high switch cost pharmaceut
product shift patent gener drug produc look
minim risk simplifi regulatori process use
ingredi chang drug includ
binder ingredi control releas
polym must demonstr equival origin
product difficult feat consid high standard
qualiti consist requir food drug
administr failur demonstr equival would
mean gener product pass regulatori
approv gener drug produc tend stick
binder function nonact ingredi
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
odupont specialti chemic busi among
best world develop product kevlar
tyvek command price power gener
oth electron
well
posit grow profit result grow
demand semiconductor increas connect
internet thing technolog
oth dowdupont merger subsequ separ
three compani creat valu sharehold
cut cost excess manag target
improv profit margin next
odupont underinvest rel peer
limit compani abil gener new
product gain market share long term
odupont electron advanc materi
busi expos china risk
neg impact prolong trade conflict
china
odupont fail realiz synergi target
dowdupont spin-off due dis-synergi
addit oper expens stand-alon
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
dowdupont spun three compani good financi
shape total debt dupont roughli billion
ebitda time manag long-term
goal time manag dupont plan
pay least million dividend annual grow
net incom manag target pay-out
ratio dividend forecast dupont gener
signific free cash flow allow firm meet
financi oblig remain cash flow
dupont face stiff competit across chemic market
firm oper mani highli cyclic end market
residenti construct
electron could see prolong slowdown demand
end market addit guarante
dupont invest research develop
new specialti chemic product bear fruit dupont
unabl develop new product replac formula
roll patent new product fail gener
increment demand growth end user
compani abil charg premium product would
deterior major sale outsid
 compani expos fluctuat foreign
currenc like chemic produc compani
continu face possibl environment
health-rel remedi cost asbesto
liabil dupont risk litig relat
pfoa relat toxic chemic lawsuit
former subsidiari face bulk risk relat
lawsuit dupont like fund part
settlement environment cleanup
expens ultim dupont remain risk long
face lawsuit liabil relat toxic
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
chemic still part dupont
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
repres date owner name posit common share held report holder issuer
capit research manag compani
new york mellon corp
fidel manag research compani
share
fund
share
fund
doyl join dupont presid
protect technolog busi merger
close time dupont
singl compani doyl specialti product
compani dupont dowdupont
merger subsequ separ dupont emerg
specialti chemic compani
chemic exposur favor compani
focus develop new patent product
sustain price power
manag target invest roughli
sale research develop think
enough develop new product rang invest
wide-moat peer honeywel
novozym result think dupont like
abl catch competitor compani
alreadi hold market-lead posit
manag incent base metric
includ return invest capit favor
return invest capit metric think incentiv
manag invest value-ad area busi
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
first report quarter stand-alone compani sinc
spin renam dupont
report solid second-quart result higher price
ebitda flat year year pro forma basi billion
chang forecast maintain
per share fair valu estim dupont narrow-
moat rate base intangible-asset moat sourc
price power dupont specialti chemic also
unchang current price view dupont
under-valued risk-adjust basi share trade
territori
backdrop fall commod chemic input
price slow demand mani dupont end
market think price increas exclud currenc
demonstr strength price power compani
demand eventu recov think dupont well
posit long-term profit growth
safeti construct busi oper ebitda
grew year year million driven price
increas volum increas price increas came
water safeti busi volum
growth came exclus water busi
growth dupont water busi consist
long-term expect freshwat cost doubl
expect dupont water busi see increas
demand water purif filtrat technolog
dowdupont complet corteva spin-off renam
june dowdupont complet spin-off
time compani renam dupont de
nemour execut one-for-thre revers stock split
fair valu estim dupont stand-alone entiti
per share includ revers stock split
assign narrow-moat rate dupont base
intang asset moat sourc firm price power
patent specialti chemic
addit assign medium uncertainti rate
dupont typic chemic industri cyclic off-set
diversifi end-market price power
sale come automot market end
market gener total sale dupont
custom base industri exposur well diversifi
due price power compani specialti
chemic advanc materi
companywid revenu grow around next
although revenu highli diversifi dupont posit
benefit secular growth trend first dupont
automot busi benefit
electrif gener revenu per
vehicl ev versu intern combust engin
vehicl electron imag busi
major revenu come semiconductor compon
interconnect solut exposur allow
dupont benefit continu growth semiconductor
rise devic interconnect internet
thing technolog
safeti protect busi revenu
come tyvek housewrap benefit
continu recoveri hous start nutrit
bioscienc busi benefit age
requir
pharmaceut dupont lead manufactur
pharmaceut excipi use bind tablet
final assign standard stewardship rate dupont
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
ceo marc doyl dupont sinc hold
variou leadership posit prior merger
sinc merger doyl
specialti chemic busi dupont
manag focus reduc expens
achiev cost save synergi target think initi
guidelin invest research develop
seem low sale peer
honeywel novozym think
invest enough develop new patent product
think level low dupont abl
catch competitor compani alreadi
dowdupont report soft ahead corteva spin
dowdupont report weak first-quart result delay
plant lower volum across specialti
chemic segment weigh profit updat
valuat model maintain per share fair valu
estim narrow moat rate dowdupont
market react neg earn releas
send share nearli current price view
dowdupont under-valued compani prepar
spin agricultur compani name
june june dowdupont
begin trade independ separ phase
complet june dowdupont renam
dupont contain
busi continu cover
agricultur busi oper ebitda decreas
year year driven larg lower volum
bad weather delay north american plant season
earn releas manag said seed
deliveri pace late
april full-year guidanc unchang seed
busi sell directli farmer instead farm retail
delay plant season greater effect
specialti chemic busi face headwind due
lower volum across nearli segment higher raw
busi dupont face higher raw materi price
oil price rise price commod chemic input
dupont purchas typic move oil price
howev given dupont price power patent
specialti chemic compani gener rais price
cover raw materi inflat longer period
april dowdupont report preliminari result
agricultur busi compani expect first-quart
ebitda versu first quarter
flood cold weather delay start plant
season howev dowdupont expect make
profit remaind year manag guid
first half ebitda left full-year guidanc
unchang specialti product divis dowdupont
guid ebitda line previou
today announc littl impact outlook
maintain per share fair valu estim narrow-
moat rate also unchang current price view
dowdupont under-valued stock trade
agricultur input compani dowdupont
weather caus sale profit fluctuat wide
quarter quarter farmer typic wait purchas
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
volatil commod chemic busi subject
greater profit swing base high fix oper cost
make profit sensit spread brent
oil natur ga
dupont benefit multipl secular trend includ
continu
light-weight electrif
automot rise interconnect devic
requir electron compon continu growth
 hous start next decad
seed gener major revenu
hold number two seed portfolio behind bayer
roundup readi seed technolog platform agreement
expir start switch
new seed proprietari enlist platform
boost margin rang
mid-cycle forecast
crop input seed plant
howev full-year basi typic less volatil
spin commod chemic busi
june dowdupont current hold agricultur
specialti product busi compani remain
track separ two compani end
second quarter june dowdupont spin
agricultur busi known
spin-off complet dowdupont
hold specialti chemic busi renam
dupont
april dowdupont spun materi scienc
busi name spin-off first two
separ result three separ compani
busi name dupont agricultur busi
name april dowdupont began trade
ex-dow basi updat dowdupont model
fair valu estim fall per share
narrow moat rate intact
per share fair valu estim reflect dupont
fair valu estim roughli per dowdupont share
fair valu estim roughli per share
current plan spin dowdupont
june point dowdupont renam dupont
separ complet continu
cover dowdupont june dupont
thereaft maintain coverag
also lower uncertainti rate dowdupont
medium high reflect remov highli
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
good sold
incom equiti invest
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
